Skip to content

BPC-157: Side Effects & Safety

Part of the BPC-157 Complete Guide

Partner

BPC-157 (10mg)

BioLongevity Labs15% Off
Shop BPC-157

We may earn a commission if you purchase through this link, at no extra cost to you.

Safety Profile

  • No LD50 established: Toxicology studies could not determine a lethal dose even at very high concentrations — suggesting extremely low acute toxicity
  • No organ toxicity: No liver, kidney, or cardiac toxicity in repeated dosing studies
  • GI stability: Stable in gastric acid, well-tolerated orally
  • Injection site reactions: Mild, transient redness — the most common reported effect

Important Limitations

  • Most data comes from a single research group (University of Zagreb)
  • No completed human clinical trials
  • Long-term effects of supplementation are unknown
  • Angiogenesis concern: As a promoter of new blood vessel formation, theoretical concerns exist regarding use near active tumors (though no tumor promotion has been reported)

For the complete overview, see the BPC-157 complete guide.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.